Phenylephrine hydrochloride
This medicine should always be taken exactly as described in the patient leaflet or as directed by a doctor or pharmacist.
Acatar Acti Form contains phenylephrine. It is an oral decongestant. The phenylephrine in the medicine causes the constriction of small blood vessels in the nasal mucosa, which reduces its swelling, making it easier to breathe and reducing the amount of nasal discharge. Acatar Acti Form is intended for use in adults and children over 12 years of age. The indication for use of Acatar Acti Form is the temporary relief of symptoms of nasal mucosa swelling (cold) occurring in a cold, flu, or allergic rhinitis (hay fever).
Before taking Acatar Acti Form, consult a doctor or pharmacist if you have:
Consult a doctor even if the above warnings apply to past situations. If you have previously been diagnosed with intolerance to some sugars, you should consult a doctor before taking the medicine.
The medicine should not be used in children under 12 years of age.
Tell your doctor or pharmacist about all medicines you are currently taking or have recently taken, as well as any medicines you plan to take. Do not take the medicine at the same time as other medicines containing:
Consult a doctor before taking the medicine with:
Food does not reduce the absorption of the medicine, it can be taken independently of meals.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a child, consult a doctor or pharmacist before taking this medicine. Do not use during pregnancy. Do not use during breastfeeding.
While taking the medicine, be careful when driving vehicles and operating machines.
If you have previously been diagnosed with intolerance to some sugars, consult a doctor before taking the medicine.
Always take this medicine exactly as described in the patient leaflet or as directed by a doctor or pharmacist. If you have any doubts, consult a doctor or pharmacist.
Orally, 1 capsule every 4 to 6 hours (maximum 4 capsules per day).
Do not use in children under 12 years of age.
No dose reduction is needed in elderly patients. Do not use the medicine for more than 7 days without consulting a doctor.
In case of overdose, rapid heart rate, high blood pressure, vasodilation leading to a significant drop in blood pressure, and difficulty breathing may occur. If the overdose occurred no more than 1 hour ago, induce vomiting and consult a doctor, as specialized treatment in a hospital may be necessary. Treatment involves gastric lavage and administration of beta-adrenergic blockers. In case of severe poisoning, monitoring of vital functions, respiratory support, and circulation in intensive care is necessary. In case of taking a higher dose of the medicine than recommended, consult a doctor or pharmacist immediately.
Do not take a double dose to make up for a missed dose.
If you have any further doubts about taking this medicine, consult a doctor or pharmacist.
Like all medicines, Acatar Acti Form can cause side effects, although not everybody gets them. The frequency of side effects is classified as follows:
Frequent(may occur in up to 1 in 10 people):
Rare(may occur in less than 1 in 1000 people):
If you experience any side effects, including any possible side effects not listed in this leaflet, consult a doctor or pharmacist. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: +48 22 492-13-01, fax: +48 22 492-13-09, e-mail: ndl@urpl.gov.pl. Side effects can also be reported to the marketing authorization holder. By reporting side effects, you can help provide more information on the safety of the medicine.
Store at a temperature below 25°C. Keep the medicine out of sight and reach of children. Do not use the medicine after the expiry date stated on the carton and blister pack (month/year). The expiry date refers to the last day of the month. The applied labeling for the blister is: EXP - expiry date, Lot - batch number. Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
The active substance of the medicine is phenylephrine hydrochloride 12.2 mg. The other ingredients are: cornstarch, lactose monohydrate, cornstarch, magnesium stearate. Capsule: gelatin, titanium dioxide (E 171), quinoline yellow (E 104).
Yellow, elongated capsules for oral use. Packaged in a PVC/Aluminum blister pack in a carton with a leaflet. The medicine is available in packages: 12 capsules in a blister pack. Not all pack sizes may be marketed.
US Pharmacia Sp. z o.o., ul. Ziębicka 40, 50-507 Wrocław. For more detailed information, please contact: USP Zdrowie Sp. z o.o., ul. Poleczki 35, 02-822 Warsaw, tel.: +48 (22) 543 60 00.
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.